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High consistency in left ventricular MR spectra in rats in vivo allows
detecting small variations in energy status and early energy defects
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Phosphorus magnetic resonance spectroscopy (31P-MRS) makes a unique and
valuable contribution to our understanding of heart energetics, by giving the car-
diac energy status from the concentrations of ATP and phosphocreatine (PCr).
Changes in PCr/ATP ratio allow detecting energy imbalance that predicts disease
and mortality. However, localized MR techniques in vivo are often challenged by
tissue contamination and poor signal-to-noise ratio, especially in small animals.
Here we purposely aimed at demonstrating good consistency in localized car-
diac 31P-MR spectra obtained from left ventricle of rats in vivo with a surface
probe at 9.4T. For that, 3-min MR spectra and short-axis cine-MRI frames were
obtained in sinus rhythm during nine consecutive weeks in control and hyperten-
sive rats (SHR) just before the apparition of severe pathology in the later. Then a
severe tachycardia was acutely induced by isoproterenol injection (10μg/kg) and
the PCr/ATP response kinetically analyzed.
Along 9 weeks, we showed highly reproducible, steady and similar PCr/ATP
ratios in each group in spite of progressive ventricular hypertrophy in SHR rats.
Isoproterenol induced a similar tachycardia in each group (Control: 439bpm ±7,
SHR: 411bpm ± 7) but altered responses of the energetics were noted in SHR rats:
higher decrease in PCr/ATP ratio (–17.1% ± 0.75 vs. –4.7% ± 0.4, P<0.05) asso-
ciated with longer recovery time (time constant of exponential fit 23.9 ±10.8 vs.
7.3 ± 1.15min, P<0.05).
High signal-to-noise ratio in 3min-MR spectra allowed demonstrating good
consistency in follow-up assessments of PCr/ATP in left ventricle of rats in vivo.
Thanks to good consistency, small variations in energy status have been detected
in response to isoproterenol that revealed a blunted capacity in SHR rats to main-
tain energy balance. These gains offer exciting possibilities to better investigate
primary precursors detection of cardiac pathology in rodent models.
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Background: Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) is
an inherited heart muscle disease mainly caused by desmosomal gene mutations.
PKP2 is the major ARVC causing-gene and presents frequent truncating muta-
tions leading to haploinsufficiency. Large deletions of PKP2, which are not
detected with standard Sanger sequencing, have been reported in few ARVC
patients. This study aimed to compare different screening methods for detection of
large PKP2 deletions and to determine their prevalence in the ARVC population.
Methods: We included 19 patients and 1 family of 4 members with a diag-
nosis of familial ARVC, which were screened negative by Sanger sequencing.
A whole exome capture was performed with the Agilent SureSelect® all Exon
V5 50Mb kit and sequenced with a HiSeq2000®. The depth of coverage dis-
tribution of each PKP2 exon was analysed and compared to the mean
coverage distribution of the cohort. Heterozygous PKP2 deletion was sus-
pected in presence of coverage < –2 standard deviation (SD). All suspected
large deletions were confirmed with qPCR. MLPA® was performed in 50 sup-
plementary unrelated ARVC probands and in our cohort to compare the accu-
racy of this method with exome sequencing.
Results: The analysis of coverage depth identified one patient with a
heterozygous deletion of the whole PKP2 gene and in the family, a heterozy-
gous deletion of PKP2 exon 4 which cosegregrated(Figure). qPCR and
MLPA® analysis confirmed this result. The prevalence of large deletions of
PKP2 in gene negative familial ARVC was 10,5%. MLPA® identified large
PKP2 deletions in two additional unrelated probands.
Conclusion: Our study shows that large PKP2 deletions are not infrequent
in ARVC and should therefore be screened in patients with unidentified muta-
tions. This study demonstrates that whole exome sequencing is an accurate
technique to detect such mutations. However, MLPA® appears as an efficient
and costless technique in this purpose.
Abstract 0247-Figure: Heterozygous PKP2 exon 4 deletion in the family
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Beneficial systemic effects of O-GlcNAc stimulation in early phase of
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Septic shock is a worldwide burden with over 750 000 cases per years in the
US only. This pathology, characterized by a systemic inflammation, is notably
associated with a severe cardiovascular dysfunction. Recently, Hilgers et al
showed beneficial cardiovascular effects of the O-GlcNAcylation (a post-transla-
tional modification) stimulation during pro-inflammatory conditions. In this
context, we postulated that stimulation of the OGlcNacylation at the early phase
of septic shock could improve cardiovascular function. Rats received (iv) either
lipopolysaccharide (LPS, 5mg/kg) or saline. One hour after, fluid resuscitation
(15ml/kg of colloid, iv) was associated or not with glucosamine (GlcN, 180mg/kg)
or an inhibitor of O-GlcNAcase, NbutGT (10mg/kg). Two hours later, heart and
blood samples were collected to evaluate global cardiac proteins O-GlcNAcylation
by western-blot, to evaluate blood biological parameters (lactate, troponin T, cre-
atinin), respectively. NButGT and GlcN treatment increased total O-GlcNAc by
200 and 300% respectively, versus LPS with colloid rats. Those treatments pro-
duced an acidosis (lactate: saline 2.80±0.43, LPS 6.37±0.54, NButGT 3.01±0.26
mmol/L), an improvement of cardiac dysfuntion (troponin T: saline 6.17±1.15,
LPS 117.40±48.81, NButGT 30.89±16.82, GlcN 54.59±32.08 mmol/L) as well as
renal dysfunction (creatinine: saline 25.37±1.31, LPS 77.50±7.81, NButGT
33.67±5.10, GlcN 33.67±5,10μmol/L). These results demonstrate a distinct
improvement of organ function (heart and kidney) with an O-GlcNAcylation stim-
ulation during early phase of sepsis. This study must be completed by the analysis
of vasomotricity and inflammation under the O-GlcNAcylation stimulation and to
determine the underlying mechanisms and their influence on mortality.
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